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ABSTRACT 
Introduction 
In developing countries, diarrhoea is a major cause of morbidity and mortality among 
children under five years of age. This study aimed to determine the effect of age and HIV 
infection status on incidence of acute gastroenteritis and to identify risk factors associated 
with death and prolonged hospitalisation.  
 
Methods 
A secondary data analysis was performed using an existing cohort of children enrolled on a 
pneumococcal vaccine efficacy study performed in 1998-2005 in Soweto.  
 
Results 
The incidence rate of acute gastroenteritis requiring hospitalisation was 10.13 (CI95% 9.68, 
10.58) per 1000 person years. Incidence was highest in those under six months of age, 
decreased with increasing age, and was 5.42 times (CI95% 4.89, 6.01) higher in those 
infected with HIV compared to that in HIV-uninfected children. HIV-infected children 
were more likely to be malnourished, have severe dehydration and have a concomitant 
diagnosis of lower respiratory tract infection (LRTI). HIV-infected children were four 
times more likely to die in hospital (OR 3.99 CI95% 2.04, 7.81) and almost twice as likely to 
be hospitalized > 2 days (OR 1.81 CI95% 1.38, 2.38) compared to HIV-uninfected children. 
Presence of malnutrition, severe dehydration and a concomitant diagnosis of LRTI were 
also significant risk factors for death and prolonged hospitalisation. 
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Conclusions 
 
Acute gastroenteritis is an important cause of hospitalisation in children under 2 years, 
especially among HIV-infected children. Prevention and management of severe 
dehydration, malnutrition, HIV infection and concomitant LRTI need to be targeted to 
decrease mortality and shorten the duration of hospitalisation in children admitted with 
acute gastroenteritis.  
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1. INTRODUCTION 
 
1.1 The Global and Local Burden of Diarrhoeal Disease 
 
Despite a decline in child mortality, preventable and treatable diseases such as pneumonia, 
diarrhoea, malnutrition, malaria and measles are still the leading cause of death in children. 
Worldwide diarrhoea is estimated to account for 18% of the 10.6 million annual deaths in 
children younger than five years of age. The burden of disease is greatest in the African 
region, which accounts for 40% of deaths from diarrhoea despite only contributing to 18% 
of the world under-five population (1). Mortality from diarrhoea has decreased over the 
past forty years, however, the incidence has remained unchanged and morbidity remains 
high (2). High incidence rates are clinically significant as diarrhoea in children can have an 
adverse effect on growth as well as physical and cognitive function (3, 4). In South Africa, 
diarrhoeal disease is still a major cause of morbidity and mortality in the under-five age 
group, accounting for just over 10% of deaths in this age group in 2000 (5).  
 
1.2 The Burden of Rotavirus Disease 
 
Acute diarrhoea can be caused by a variety of viral, bacterial and parasitic enteropathogens 
but rotavirus is recognised as the most important cause of severe gastroenteritis in infants 
and young children throughout the world, and generally results in more severe 
gastroenteritis than that caused by other enteropathogens (6, 7). The contribution of the 
various pathogens to diarrhoeal illness often varies between countries depending on 
geographical and socio-economic conditions (8).  
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Rotavirus is the main cause of acute gastroenteritis worldwide, accounting for 527 000 
deaths per year and 29% of all deaths due to diarrhoea in children under five years of age 
in 2004 (9). A review of studies published from 1986 to 1999 found that rotavirus was 
responsible for a median of 22% of cases of severe diarrhoea in children (10). An updated 
review of studies published from 2000 to 2004 showed that an increased proportion of 
hospitalisations were due to rotavirus compared to preceding years, and that rotavirus now 
accounted for 39% of severe diarrhoea cases (11). Hospital-based global sentinel 
surveillance data show that rotavirus infection accounts for about 40% of hospitalisations 
for diarrhoea in children under 5 years worldwide (12). Rotavirus is isolated more 
frequently in children who are hospitalised with acute gastroenteritis (severe disease) than 
those in the community (7), often resulting in severe dehydrating diarrhoea. More than 
80% of all deaths related to rotavirus were estimated to occur in the developing countries 
of sub-Saharan Africa and south Asia (11).  
 
Rotavirus infection has been shown to be most common in children aged 6 to 24 months 
(13), however, Steele et al reported that a sizeable proportion of infants under 6 months of 
age also developed rotavirus illness (14). In developed countries the majority of children 
with rotavirus infection are in their second year of life, whereas in developing countries 
just over 80% of hospitalisations for rotavirus occurred during the first year of life, with 
38% before 6 months of age (7, 15). In an observational study in Greece, children with 
rotavirus infection were more likely to have severe gastroenteritis, be hospitalised, and 
have a longer duration of hospitalisation compared to gastroenteritis due to other pathogens 
(16). They also had a higher severity score (17).  
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Diarrhoea occurs year-round but there is usually a period with increased rotavirus 
prevalence. In a review of fifteen African countries, rotavirus infection occurred 
throughout the year but seasonal peaks were commoner in the dry rather than the wet 
seasons, although this did not apply to all countries (7). In Southern Africa there was 
generally a single peak of rotavirus infection during the dry season (autumn and winter). In 
South Africa, Steele et al reported a defined seasonal pattern with one peak in May 
(autumn) and a second smaller peak in August and September (late winter and early 
spring) (14). 
 
1.3 Diarrhoea and Human Immunodeficiency Virus (HIV) Infection 
 
HIV infection is common among children in many sub-Saharan African countries, 
including South Africa, with high mortality rates (18,19). The burden of paediatric HIV 
infection is highest among infants and young children due to the high prevalence of 
maternal HIV infection and subsequent mother to child transmission. HIV infected 
children are more likely to be malnourished, to have been previously hospitalised, to have 
a longer duration of hospitalisation, are less likely to respond to antibiotic therapy and 
more likely to die during admission compared to HIV-uninfected children (18, 19).  
Diarrhoeal disease has been shown to be a leading cause of morbidity and mortality in 
HIV-infected children (20, 21). The incidence , duration, severity and mortality from 
diarrhoea is greater in HIV-infected children (21, 22).  
 
In a study performed in HIV-infected and HIV-uninfected children hospitalised for 
diarrhoea at Chris Hani Baragwanath Hospital (CHBH), HIV-infected children were more 
likely to have prolonged diarrhoea, require hospitalisation for more than 4 days (odds ratio 
(OR) 5.11, 95% confidence interval (CI95%) 1.49, 17.52) and had a higher rate of 
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concomitant pneumonia compared to HIV-uninfected children (22). Pavia et al showed 
that HIV-infected children had more frequent episodes of diarrhoea, were more likely to 
present with severe dehydration, to have persistent diarrhoea and have a fatal outcome. 
Diarrhoea among HIV-infected children was associated with malnutrition and advanced 
HIV disease in the mother (21). In Zaire HIV-infected infants had more recurrent and 
persistent diarrhoea, and the incidence of persistent diarrhoea in HIV-exposed uninfected 
infants was nearly twice that of HIV-unexposed uninfected infants (20). HIV-infected 
children had higher frequency of malnutrition, persistent and recurrent diarrhoea and 
recurrent hospital admissions in a rural South African study (23). 
 
There is little evidence to suggest that the aetiology of diarrhoea among HIV-infected 
children is different to that in HIV-uninfected children. Diarrhoea in adults with Acquired 
Immunodeficiency Syndrome (AIDS) has been associated with opportunistic infections, 
for example Isospora belli, but this has not been observed in children (22). The frequency 
of excretion of enteric viruses was shown to be greater in HIV-infected children compared 
to HIV-uninfected children but associated illness was not more common or severe in the 
HIV-infected children (24). Asymptomatic and mildly symptomatic HIV infection has not 
been shown to influence the outcome of rotavirus infection. In a study of Malawian 
children, HIV-infected children shed rotavirus in their stools for a longer period but this 
did not lead to increased incidence or severity of diarrhoea. Rotavirus does not seem to be 
an opportunistic pathogen in HIV-infected children (25). No data is available on the course 
of rotavirus infection in severely immunocompromised children.  
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1.4 Prevention of Diarrhoeal Disease 
 
Prevention remains an important means to decrease both morbidity and mortality from 
acute gastroenteritis. Previous efforts focused mainly on early treatment of diarrhoea with 
oral rehydration, but the availability of an effective rotavirus vaccine provides a new way 
to address this problem. Preventative interventions for diarrhoeal disease and its 
complications include improvement of water quality and sanitation, promotion of 
breastfeeding, higher rates of measles immunization, and introduction of treatment 
programs focused on oral rehydration.  These interventions have decreased mortality 
associated with bacterial and parasitic infections, but have not reduced the incidence of 
rotavirus diarrhoea (26).  
 
Rotavirus infections occur universally in children with a similar incidence in developing 
and developed countries suggesting that rotavirus infection cannot be prevented by 
improvements in water and sanitation (27). Bacterial and parasitic agents are transmitted 
mainly through contaminated food and water, whereas rotavirus is often spread from 
person to person (11). Prevention of bacterial and parasitic diarrhoea by improvement in 
hygiene and sanitation most likely account for the increasing proportion of severe 
diarrhoea cases attributable to rotavirus over recent years. Children are more likely to die 
in developing countries due to poor access to oral rehydration therapy and the high 
prevalence of malnutrition (10).  
 
Immunization is recognized as the most cost-effective public health intervention in 
developing countries (13). The introduction of a rotavirus vaccine will provide a public 
health tool to address mortality and morbidity from rotavirus disease, and thus from acute 
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gastroenteritis in general. An estimated 16% of all diarrhoeal deaths in children under five 
could be prevented by introduction of an effective vaccine (27). The first effective 
rotavirus vaccine was introduced into the routine immunization programme in the United 
States of America (USA) in 1998 but was withdrawn after it was associated with an 
increased risk of intussusception (28). Following this, two oral live-attenuated rotavirus 
vaccines have been evaluated in large clinical trials and were found to be safe and 
efficacious for the prevention of rotavirus gastroenteritis (29, 30). These are Rotarix™ 
(Glaxo-SmithKline Biologicals (GSK), Rixensart, Belgium), a monovalent human 
rotavirus vaccine and RotaTeq™ (Merck & Co, New Jersey, USA), a pentavalent human-
bovine reassortment rotavirus vaccine. These are both licenced in South Africa and 
Rotarix™ was included in the Expanded Programme on Immunization (EPI) in South 
Africa since August 2009.  
 
Of special note is that the rotavirus vaccine gave 42% protection against hospitalisation for 
gastroenteritis of any cause (29), which leads to a decrease in the overall burden of acute 
gastroenteritis. The vaccine has been shown not to interfere with other childhood 
vaccinations, including oral polio vaccine (OPV) (31). A study in HIV-infected children in 
South Africa showed that Rotarix was well tolerated and immunogenic in this group of 
children, when co-administered with the routine vaccines in the EPI schedule (32). An 
efficacy study conducted in South Africa using Rotarix™ showed vaccine efficacy in 
children under one year of age to be 76.9% (CI95% 56.9, 88.4) and although vaccine 
efficacy may be lower than that in developed countries, the public health impact is 
expected to be greater due to the higher burden of disease (33).  
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Rotavirus diarrhoea occurs at an earlier age in developing countries compared to developed 
countries so children in developing countries will require complete vaccination earlier (13). 
The recommendation is to vaccinate all infants, without targeting only those with risk 
factors, with a mass immunization program starting at the age of six weeks (34). Rotarix™ 
will be given to South African infants at 6 and 14 weeks in conjunction with the existing 
vaccines in the vaccine schedule. 
 
1.5 Severity of Diarrhoea 
 
A measure of the severity of an episode of acute gastroenteritis is important as severity 
may vary by age, HIV infection status or other risk factors. A widely used scoring system 
is the Vesikari scale, which assigns a score from 0 to 20 based on duration and intensity of 
diarrhoea and vomiting, intensity of fever, presence of dehydration and hospitalisation 
(35). This scoring system has been used in the clinical trials investigating safety and 
efficacy of candidate rotavirus vaccines, as well as some of the observational trials where a 
modified score was used. Other observational studies have relied on level of dehydration, 
duration of diarrhoea prior to hospitalisation, duration of hospitalisation and death as 
indicators of severity. Most frequently clinical grading of severity is done by grading the 
degree of dehydration according to signs and symptoms that reflect the amount of fluid 
lost. 
 
1.6 Risk Factors for Poor Outcome  
 
The identification of risk factors associated with severe acute gastroenteritis as well as 
identifying predictors of poor outcome, can aid in designing prevention strategies. With 
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high HIV prevalence rates in South African children, the impact of HIV infection on the 
incidence of and outcomes from acute gastroenteritis is important when determining and 
tailoring interventions. Sex, age, non breastfeeding, low birth weight, HIV infection, 
malnutrition and co-morbidities have been associated with poor outcome in children with 
diarrhoea. 
 
Sex has been associated with incidence of acute gastroenteritis, with a relative risk of 
males versus females equal to 1.08 (CI95%1.04, 1.11). Age has been identified as an 
important risk factor for acute gastroenteritis, with incidence decreasing with increasing 
age (36). About two-thirds of all rotavirus gastroenteritis cases in the REVEAL study in 
Europe occurred in the 6 to 23 month age group (37). In a review of the epidemiology of 
rotavirus infection in hospitalised South African children, it was found that more than 95% 
of rotavirus cases occurred in children under 18 months of age (15). Eighty-one percent of 
children hospitalized with rotavirus infection were under one year of age.  
 
Other risks for severe acute gastroenteritis include premature birth and low birth weight 
and a significant association was found between hospitalisation for rotavirus acute 
gastroenteritis and low birth weight (34, 38). Nosocomially-acquired rotavirus infection in 
neonates has been shown to be milder and provide natural protection against rotavirus 
disease later in childhood, although premature infants and those in neonatal intensive care 
unit (ICU) with rotavirus infection may have a more severe course (34). 
 
Non breastfeeding has been identified as a risk factor for all cause acute gastroenteritis 
death and severe malnutrition and lack of breastfeeding were found to be important 
independent risk factors for death in children hospitalised for diarrhoea (39). Observational 
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studies have shown that exclusive breastfeeding is protective against diarrhoeal disease in 
both developed and developing countries, whereas the protective effect against rotavirus 
disease specifically has been variable (40). A study in Europe has shown that exclusive 
breastfeeding of infants is protective against rotavirus disease (41) but a large study by 
Glass et al concluded that results do not support a protective role for breastfeeding against 
severe rotavirus disease beyond the first months of life (42). An American study found 
breast feeding to be protective against hospitalisation in infants under six months of age 
(43). The protective effect may only be transient and lost when breastfeeding is stopped 
(44). Breastfeeding may postpone rather than prevent disease.  
 
Malnutrition has been identified as a risk factor for diarrhoeal disease, with a longer 
duration of diarrhoea and higher incidence of dehydration in malnourished children (39). 
Animal and human studies have suggested that malnutrition may contribute to the severity 
of disease caused by rotavirus, in particular increased duration of diarrhoea (34). 
Malnutrition may interfere with regeneration of the intestinal villi. Malnutrition has been 
shown to increase the risk of mortality, however, in a study conducted in Malawi, after 
controlling for age and HIV infection, severity of disease was not influenced by nutritional 
status (25).  
 
Co-morbidities have also been associated with poor outcome, with presence of pneumonia 
being a major prognostic indicator for death in children attending a diarrhoea treatment 
centre in Bangladesh (39). A longer hospital stay was associated with a co-diagnosis of 
pneumonia in a South African study (22). Respiratory tract infections often occurred 
together with rotavirus gastroenteritis in a study from Sierra Leone. The most common co-
morbidities were malaria followed by respiratory tract infections (17). In a review, 23% of 
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rotavirus cases had at least one other enteropathogen identified and mixed infections were 
associated with malnutrition and prolonged diarrhoea (7) Presence of bacteraemia has also 
been associated with death from diarrhoea (23). 
  
Xerophthalmia and measles infection in the previous 3 months were significantly 
associated with death from diarrhoea. Duration of diarrhoea between 7 and 14 days, 
children presenting with moderate or severe dehydration, children of mothers with low 
education and low household income were also at greater risk of death (39).  
 
1.7 Justification and Study Objectives 
 
There is a lack of burden of disease data for severe acute gastroenteritis in South Africa, 
especially in HIV-infected children. These data are vital to inform policy regarding the 
cost-effectiveness of interventions such as vaccines. Especially pertinent to South Africa is 
the high prevalence of HIV infection with the national prevalence of HIV among antenatal 
clinic attendees increasing from 22.4% in 1999 to 30.2% in 2005. The prevalence in 
Gauteng was slightly higher than the national prevalence, with corresponding antenatal 
HIV prevalence in 2005 of 32.4% (45). The impact of HIV infection on the incidence of 
acute gastroenteritis is thus important in our community. There is an urgent need for 
effective interventions to prevent diarrhoeal deaths and morbidity in children under five 
years of age. The identification of risk factors for severe acute gastroenteritis and poor 
outcome is the key to targeting interventions aimed at reducing diarrhoeal disease 
morbidity and mortality.  
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Childhood mortality and morbidity can be reduced through routine immunization of 
infants. With effective rotavirus vaccines available the burden of disease needs to be 
evaluated to aid in determining the cost-effectiveness of vaccination against rotavirus. The 
identification of rotavirus in the stool is not part of the routine investigations for a child 
with diarrhoea in most hospitals, as it does not change the management of the disease. 
Even without microbiological evidence of rotavirus infection, seasonal and age distribution 
of acute gastroenteritis consistent with rotavirus disease may guide policy decisions for 
future introduction of a rotavirus vaccine. A study in Italy evaluated the burden of acute 
gastroenteritis as an indirect measure of rotavirus disease, as rotavirus gastroenteritis is 
responsible for a large proportion of all cases of acute gastroenteritis (36). Most acute 
gastroenteritis cases in Italy had the same age and calendar distribution as rotavirus 
disease. In the same way assessing the overall burden of acute gastroenteritis in Sowetan 
children may give an estimation of the burden of rotavirus disease. 
 
This study aims to determine the incidence rate of hospitalisation for acute gastroenteritis 
in a cohort of Sowetan children under five years of age, as well as to determine risk factors 
associated with poor outcome in children with severe acute gastroenteritis. This will give 
baseline incidence of severe acute gastroenteritis prior to introduction of the rotavirus 
vaccine into the routine immunization schedule. Surveillance of acute gastroenteritis post 
vaccine introduction will then allow investigation of the impact of the vaccine on the 
incidence of hospitalisation for acute gastroenteritis. Acute episodes of gastroenteritis will 
be considered, with the exclusion of episodes of persistent diarrhoea. Although persistent 
diarrhoea contributes largely to the overall burden of diarrhoeal disease, this study focuses 
on acute severe gastroenteritis and estimates for rotavirus disease burden. 
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Objectives  
1. To determine the incidence of hospitalisation for acute gastroenteritis in a cohort of 
Soweto children under five years of age, and thus estimate the burden of rotavirus 
disease. 
2. To determine the effect of age and HIV status on incidence of hospitalisation for acute 
gastroenteritis.  
3. To determine the risk factors associated with mortality and prolonged hospitalisation in 
children hospitalised with acute gastroenteritis over a five-year period.  
 
2. MATERIALS AND METHODS 
 
2.1 Details of the original study 
 
A study investigating the efficacy of a pneumococcal conjugate vaccine (PCV) was 
conducted in Soweto from 1998-2005 at the CHBH in Soweto. Enrolment began on 2 
March 1998, and ended on 30 October 2000. Follow up continued until October 2005. This 
study was a double-blind, placebo-controlled trial that included 39 836 children who were 
randomised to receive either a nine-valent pneumococcal conjugate vaccine or placebo at 
6, 10 and 14 weeks of age (46). The study was approved by the Committee for the Study of 
Human Subjects at the University of the Witwatersrand, and permission was obtained from 
the Medicines Control Council of South Africa (Appendix A). Written informed consent 
explaining all aspects of the study was obtained from a parent or guardian before 
enrolment on the trial. Study participants were identified by a unique study number in 
order to protect confidentiality.  
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2.2 Study population 
 
The participants were recruited from clinics in the Soweto area. Infants aged 28 to 84 days 
were eligible for inclusion in the study if they were unvaccinated or had only received 
OPV and Bacille Calmette-Guérin (BCG) at birth. Exclusion criteria included progressive 
underlying neurological disorder, a history of seizures or infantile spasms, or children 
planning to leave the Soweto area and that could not be followed up. In addition to PCV or 
placebo, all study participants received all other vaccinations which were included in the 
EPI schedule at the time - vaccination against diphtheria, tetanus, pertussis, Hepatitis B and 
polio was given. Twenty-four hour passive surveillance was conducted at the paediatric 
admission ward of the CHBH, a tertiary hospital serving the Soweto area, for the duration 
of the study period.  
 
During the PCV efficacy trial follow-up period, approximately 24 000 children were born 
in Soweto annually, approximately 17 000 at the hospital and the remainder at local clinics. 
It is estimated that approximately 90% of children from the Soweto area requiring 
hospitalisation are admitted to CHBH. There are 164 beds for general paediatric medical 
admissions (children < 12 years of age) and 6000 children are admitted annually (19). 
 
All hospitalisations of study participants at CHBH for any cause were identified by study 
staff, a case report form completed and an examination performed by a study doctor. The 
case report form included information on symptoms, clinical signs, physician diagnosis, 
estimated severity of dehydration based on the attending physician assessment, outcome 
and laboratory results (Appendix B). Blood and respiratory samples were collected on 
participants by study staff. The study doctors were not involved in the decision to 
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hospitalise a child, or in the child’s care or any management decisions while in hospital. 
There was no active follow up of enrolled cases. 
 
Standard of care of all children admitted with acute gastroenteritis included rehydration, 
either oral or intravenous, correction of any electrolyte abnormalities and early feeding. 
Uncomplicated gastroenteritis cases merely requiring fluid replacement were usually 
admitted to the gastroenteritis unit (GEU), whereas more complicated cases or those with 
multiple diagnoses were admitted to the general paediatric wards. Investigations were done 
as per the attending ward doctor and may have included blood culture, measurement of 
blood counts, C-reactive protein (CRP), electrolytes and HIV testing as indicated. 
Antiretroviral therapy (ART) for HIV-infected children was not standard of care in South 
Africa during this time and most children infected with HIV during the study period did 
not receive ART. During the recruitment period of this study, antiretrovirals for prevention 
of mother-to-child transmission of HIV were not routinely given to mothers and infants at 
delivery in the maternity wards.  
 
Based on the measured prevalence of HIV infection among women attending antenatal 
clinics during the duration of the study period, it was estimated that 24.87% of the children 
enrolled onto the study were born to HIV-infected mothers. The vertical transmission rate, 
in the absence of antiretroviral intervention, from mother to child was estimated to be 26%, 
and thus, 6.47% of the children recruited into the study were estimated to be HIV-   
infected (47).  
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2.3 Study design 
 
Using the existing cohort of children enrolled on the PCV efficacy study, a secondary data 
analysis was performed. Using a cohort study design, the incidence of hospitalisation for 
acute gastroenteritis was determined in this cohort of children under five years of age. 
Total person years of observation were calculated for each study participant. A subset of 
the total cohort, i.e. those admitted with a primary or secondary diagnosis of acute 
gastroenteritis, were then analysed to determine risk factors associated with acute 
gastroenteritis mortality and prolonged hospitalisation. Although incidence calculations 
made use of the data of the total cohort, this subset of participants looked at data at a 
specific time point when hospitalised for acute gastroenteritis. These data were, thus, no 
longer time-dependent but cross-sectional in nature, and analysed as such. 
 
2.4 Study sample 
 
A sample size calculation was not performed as the size of the study population had 
already been determined. However, calculations were performed to determine the precision 
of results based on the existing sample size. The incidence of diarrhoea has been estimated 
as 3.8 episodes per child per year in children under one year of age, and 2.1 episodes per 
child per year in children aged 1-4 years (10). If this is extrapolated to our cohort of 39 836  
children, we would expect about 151540 episodes of diarrhoea in the first year of life, and 
approximately 334984 episodes of diarrhoea over the remaining 4 year period of follow up. 
A study from Chile showed that 1.5% of diarrhoeal episodes in infants < 11 months 
required hospitalisation compared to 0.2% of those aged 1-4 years and these proportions 
have been used to estimate global diarrhoeal episodes (10). Using the cohort of 39 836 and 
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assuming hospitalisation rates of acute gastroenteritis as above, the estimation would be 
within 0.1% of the true proportion hospitalised in those under 1 year and within 0.02%  in 
those aged 1-4 years.  
 
2.5 Data sources 
 
The dataset was made available as a single Stata file, including all variables of participants 
enrolled on the pneumococcal vaccine trial. A template of the data collection form was 
made available and variables in the dataset were checked against the data collection form 
template. Codes were provided for any variables not present on the form but which had 
been created in the database for previous analyses. There were a total of 43 910 entries and 
259 variables. Multiple entries existed for participants with more than one hospitalisation 
during the study period, so there could be more than one observation per study participant 
(and study identification number) but with different admission dates reflecting separate 
admissions. A separate dataset existed recording the weight of the child at admission. 
These additional data were merged into the master dataset matching entries on study 
identification number and admission date.  
 
2.6 Exclusions and Definitions  
 
Any admission occurring once a child was five years or older was not included in the 
analysis. Any re-admission of a child occurring within two weeks of a previous admission 
in the same child was excluded from the analysis, as such an re-admission was most likely 
due to the same disease process as the prior admission, a relapse of the previous disease or 
as a result of a hospital-acquired (nosocomial) infection.  
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A single episode of acute gastroenteritis is usually defined as ≥ three loose stools in any 24 
hour period with duration < 14 days, occurring not less than 30 days after a previous 
episode of diarrhoea (World Health Organisation (WHO)). However, some of this 
information was either not collected on the case report form, for example, history of an 
episode of diarrhoea in the past 30 days, or the number of missing observations for the 
variable precluded the use of this variable to define an episode of acute gastroenteritis (for 
example, frequency of diarrhoea in a 24-hour period had a high proportion of missing 
values). A physician discharge diagnosis was, thus, used to identify all hospitalisations for 
acute gastroenteritis. Diagnosis fields in the database were both descriptive (text) and 
numeric codes based on the International Classification of Diseases, 9th Revision (ICD-9) 
(48), and both fields were used to identify acute gastroenteritis cases. Those with duration 
of diarrhoea greater than 14 days on admission were then excluded. A child admitted with 
acute gastroenteritis that went on to have persistent diarrhoea was still identified as an 
acute diarrhoeal episode. Frequency of diarrhoea was not used for defining an acute 
gastroenteritis episode, as values were frequently missing for this variable. 
 
Episode of severe acute gastroenteritis: any hospitalisation of a child with a physician 
diagnosis of acute gastroenteritis. There could be more than one episode per participant, 
providing subsequent hospitalisations occurred more than two weeks after the previous 
hospitalisation. All analysis was performed using the number of episodes of acute 
gastroenteritis, not number of patients.   
 
Physician diagnosis of acute gastroenteritis: A primary or secondary text diagnosis of 
“dysentery” or “gastroenteritis”, and / or a primary or secondary ICD-9 diagnosis code of 
003.0, 004, 008.0, 008.5, 008.8, or 009.3 (Appendix C). Those with duration of diarrhoea 
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≥14 days were excluded as per the WHO definition of persistent diarrhoea. Those with a 
text diagnosis of “chronic diarrhoea” or “persistent diarrhoea” were not included.  
 
2.7 Measurement of dependent and independent variables 
 
The outcome (dependent) measures considered for this analysis were in-hospital mortality 
associated with admission for acute gastroenteritis and duration of hospitalisation for acute 
gastroenteritis in days. Risk factors (independent) measured were age, sex, gestational age, 
HIV infection status, presence of malnutrition, degree of dehydration, and a concomitant 
diagnosis of a lower respiratory tract infection (LRTI). Measurement of each of these risk 
factors is described below. 
 
Outcome of a study participant was described as either death during hospitalisation for an 
episode of acute gastroenteritis, or discharge from the hospital. Mortality was classified as 
a dichotomous variable whereby participants were assigned to either death in hospital or 
discharge from hospital. Duration of hospitalisation for an episode of acute gastroenteritis 
was defined as the number of days from the date of admission to the date of outcome 
(discharge or death). i.e. date of outcome minus date of admission. Duration of 
hospitalisation was a continuous variable in the dataset; and could have been treated as 
such in the analysis. However, duration of hospitalisation was rather represented as a 
dichotomous variable, as this has more clinical application for the physician who may not 
want to predict the length of hospitalisation but merely to determine whether, on 
admission, children with certain risk factors may be more likely to be hospitalised for a 
longer period. Those with duration of hospitalisation greater than the median were 
considered to have a prolonged hospitalisation.  
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Age at study enrolment was calculated as date of first study visit minus date of birth. Age 
at admission was calculated as date of admission minus date of birth. Age at admission was 
categorised into age groups for incidence rate calculations. Age groups were generated as 
follows: < 6 months, 6-11.9 months, 12-23.9 months, and 24-59.9 months. Age at 
admission, in months, was also considered as a continuous variable in univariate and 
multivariate analysis to investigate the association between age and the above-mentioned 
outcomes. Questions on both birth weight and gestational age were included in the case 
report form, however, birth weight was missing for most patients in the dataset. Gestational 
age was, thus used as a risk factor and categorised in those who were born preterm (< 37 
weeks gestation at birth) and those who were term (≥37 weeks gestation at birth). 
 
Although HIV enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction 
(PCR) results were available for some participants (obtained during the hospital 
admission), at this time routine HIV testing was not done in all paediatric patients admitted 
to CHBH. Blood drawn by study doctors was, therefore, tested to determine HIV status, as 
per study protocol approved by the Ethics Committee. An HIV ELISA antibody test was 
performed in children 18 months of age and older, and an HIV PCR in those under 18 
months of age with a reactive HIV ELISA test or clinical suspicion of HIV-infection.  
These results were recorded in the database and used in this analysis.  
 
Those with a positive HIV ELISA (≥ 18 months) or a positive PCR (< 18 months) were 
considered as HIV-infected. Children with a negative HIV ELISA or PCR were considered 
HIV-uninfected. Those with a missing or indeterminate HIV result were considered to 
have unknown HIV status. There was no information in the database on whether infants 
were born to HIV-infected mothers or not. For incidence rate calculations, stratified by 
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HIV infection status, those with unknown HIV status were considered to be HIV-
uninfected. Any misclassification of HIV-infected children as HIV-uninfected in those 
with unknown HIV status would underestimate the incidence in HIV-infected children. For 
all other analysis involving stratification by HIV status, those with unknown HIV status 
were excluded from the analysis.  
 
Although the Vesikari severity scoring scale is a tool frequently used to evaluate the 
severity of gastroenteritis in children in clinical trials, all the variables required to calculate 
this score were not available in the dataset. The scoring scale includes duration of 
diarrhoea, maximum number of stools per 24 hours, duration of vomiting, maximum 
number of vomiting episodes per 24 hours, temperature, dehydration and treatment (35). 
This score has been used extensively in efficacy and safety clinical trials evaluating the 
two new rotavirus vaccines. In a hospital setting, this scoring system is not practical as it is 
based on indicators spanning the entire duration of the acute gastroenteritis episode. 
Clinicians usually assess the level of dehydration at admission as an indicator of severity of 
the acute gastroenteritis episode, and express this as a percentage (commonly 2.5%, 5%, 
7.5%, 10% or greater than 10%). In the Integrated Management of Childhood Illness 
Guidelines the WHO gives guidance on assessing dehydration in children. For this analysis 
the degree of dehydration was categorised into those who were ≤2.5% dehydrated, >2.5% 
but ≤5%, >5% but ≤7.5%, and >7.5% dehydrated. Presence of severe dehydration was 
defined as a level of dehydration, as assessed clinically by the hospital physician on 
admission, of greater than 5%.  
 
Weight-for-age Z-scores for boys and girls respectively, from birth to five years (WHO 
child growth standards), were used to classify children as being malnourished or not. The 
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weight and age of each participant on admission was compared to the corresponding 
weight-for-age Z-score. Those with weight-for-age less than minus two standard deviations 
were classified as being malnourished on admission. Physicians in the hospital diagnosed 
malnutrition based on the Welcome classification (49). Diagnosis fields in the database 
were both descriptive (text) and codes based on the ICD-9 classification of disease (48). 
The case report form also recorded the presence or absence of kwashiorkor. Those 
recorded as presenting with kwashiorkor were also classified as being malnourished. In 
those participants in whom a weight on admission was not available, malnutrition was 
considered present if the physician diagnosed kwashiorkor, marasmus or marasmic-
kwashiorkor at admission. This included a descriptive diagnosis as above or an ICD-9 code 
of 260, 261, or 262 (Appendix C). Those missing an admission weight with no diagnosis of 
malnutrition by the physician were considered to be adequately nourished. 
 
Descriptive diagnosis and diagnosis codes by hospital physicians were used to categorise 
participants as having a concomitant LRTI or not on admission. LRTI included a 
descriptive diagnosis of pneumonia, bronchopneumonia, bronchiolitis and /or the 
following diagnosis codes: 466.1, 480, 481, 482, or 485 (Appendix C). Those with asthma, 
bronchiectasis, aspiration pneumonia or chronic pneumonia were not classified as having a 
LRTI. Patients with positive blood culture of a bacterial pathogen were defined as having 
bacteraemia.  
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2.8 Data processing methods  
 
All data was cleaned and analyzed using STATA version 11.0 (StataCorp, Texas, USA). 
Variables which were not needed for the present analysis were dropped. Dates were 
checked to ensure that they were formatted correctly, then edited for consistency and 
changed, if it was possible to verify these dates against another variable or the original 
data.  The date of the first visit was considered the date of entry into the trial. If the first 
visit date was missing, the child was assumed not to have been enrolled on the trial and 
was not included in the analysis. The censoring date was calculated as date of birth plus (5 
x 365.25) days (5th birthday). Text diagnosis variables were edited for spelling errors and 
recoded if necessary. ICD-9 codes were cross-checked for relevant diagnoses as these were 
needed to classify the participant as having acute gastroenteritis, malnutrition or a 
concomitant diagnosis of LRTI. 
 
Data was cleaned by performing logic, range and skip checks. Completeness of data was 
assessed by checking for missing data. The number of missing values was documented for 
each variable. Categorical variables were tabulated to check for invalid options. These 
were corrected if possible, for example from small letters to capitals, or set to missing if 
entries were invalid and could not be verified. Continuous variables were summarised and 
the range of values checked to ensure these values were within possible limits. Entries that 
were not possible, for example gestational age of 50 weeks, were checked if this was 
possible or set to missing if the value could not be verified. Continuous variables were 
assessed for normality, as this determined whether parametric or non-parametric tests were 
used for analysis. New variables were created for defining and categorising independent 
and dependent variables as necessary, based on definitions as stated previously.  
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2.9 Data analysis 
 
The total number of admissions was counted, regardless of admission diagnosis and the 
proportion of these with a primary or secondary diagnosis of acute gastroenteritis was 
calculated. In those with a repeat admission within two weeks of an admission, the 
subsequent admission was excluded as this admission would most likely reflect the same 
disease process or a nosocomial infection. The first admission for the child was included. 
Incidence rates were calculated, together with a 95% confidence interval (CI95%), using 
person time analysis. The censoring point was the date the participant turned five or death 
(whichever occurred first), and follow up times were calculated accordingly. The total 
number of acute gastroenteritis episodes was used in the numerator and the total person 
years contributed by all those in the cohort in the denominator. Children can have more 
than one episode of diarrhoea so are at risk for the entire follow up period unless they were 
lost to follow up or died during the study period. Incidence rates in the placebo and vaccine 
groups were compared and incidence was stratified by age category (as previously 
defined).  
 
HIV infection status was not determined in all those enrolled on the study, only those who 
had been hospitalised during the study period. It was, therefore, not possible to calculate 
incidence rates stratified by HIV infection status using person time analysis, as above. The 
HIV prevalence in the cohort had been estimated to be 6.5% in the original study (47). This 
estimation was used to determine the denominators for cumulative incidence calculations 
stratified by HIV infection status in this analysis. Those with an indeterminate or unknown 
HIV status were considered HIV-uninfected for the purposes of cumulative incidence 
calculations.  
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The initial number of children at risk was the number of children at enrolment. For each 
age group the denominator was estimated as the number of children still alive at the 
midpoint of the interval (calculated as the average of those alive at the beginning and end 
of the period). These estimations for HIV-infected and uninfected children are shown in 
Appendix D. The number of acute gastroenteritis episodes in each interval was used in the 
numerator. A relative risk (RR) was calculated (with CI95%) to assess significant 
differences in the incidence of acute gastroenteritis between those who were HIV-infected 
and HIV-uninfected. Incidence could not be compared across age categories as the time 
interval varied in each age category.  
 
The number of episodes of acute gastroenteritis was plotted by month to investigate 
seasonality of acute gastroenteritis during the study period, and this was compared to that 
of total hospital admissions for the same month and year. 
 
All episodes of acute gastroenteritis (as previously defined) were analysed as cross-
sectional data. The descriptive component included a description of cases by various 
demographic factors. Each admission was regarded as a separate event for the analysis, 
even if the participant had been admitted previously or was admitted subsequently during 
the study follow up period, provided the time between admissions was greater than 2 
weeks. The mean (± standard deviation (SD)) was calculated for normally distributed data, 
the median and interquartile range (IQR) for skewed data, and frequencies for categorical 
data. Characteristics of all children admitted with acute gastroenteritis were determined 
and then stratified by HIV infection status to investigate any differences between HIV-
infected and HIV-uninfected children. Only children with a known HIV result were 
included in the analysis. Presenting symptoms and severity indicators were also compared 
 25
between HIV-infected and HIV-uninfected children. Laboratory results were analysed if 
these were available. 
 
Continuous variables were compared using a t test (difference between the means) for 
normally distributed data or Wilkoxon Ranksum test (Mann Whitney) for data which was 
not normally distributed. The association between categorical variables was tested using 
the chi square test or Fisher’s exact test. All tests were 2-sided and a p-value < 0.05 was 
considered statistically significant.  
 
The analytical component included both univariate and multivariate analysis. Risk factors 
associated with mortality and prolonged hospitalisation were first investigated using 
univariate analysis. The chi square test was used to assess the relationship between 
categorical risk factors and mortality, as well as between categorical risk factors and 
prolonged hospitalisation. The t test (for comparison of normally distributed continuous 
variables) or Mann-Whitney test (for comparison of continuous variables not normally 
distributed) was used to test differences in continuous variables by outcome. Multivariate 
analysis was done using logistic regression models to predict risk factors for mortality and 
prolonged hospitalisation. Forward selection was used to determine inclusion of risk 
factors in the final model, with the most significant variable in the univariate analysis 
introduced into the model first. Risk factors were then introduced into the model one by 
one, and retained in the model if there was significant improvement (as assessed by 
improvement in the -2 log likelihood) in the model after addition of the risk factor. 
Adjusted and unadjusted odds ratios, together with estimated 95% confidence intervals 
were calculated.  
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Confounding refers to a mixing of effects and there is distortion of the estimated effect of 
an exposure on an outcome caused by the presence of a third variable, which is associated 
with both the exposure and the outcome. This third variable must not be an intermediate 
step in the causal pathway between exposure and outcome. Effect measure modification is 
a situation where the association between an exposure and an outcome varies by levels of a 
third factor. Confounding can be controlled for in the analysis, whereas effect modification 
is a real effect and needs to be reported. A variable can be both a confounder and an effect 
modifier. Stratification is useful to detect both confounding and effect modification. Effect 
measure modification and confounding was evaluated using the Mantel Hanzel method. If 
the stratified odds ratios were heterogenous but the combined OR was different to the 
crude OR, confounding was considered to be present. Confounding could be adjusted for 
in the multivariate analysis and a combined OR reported. If the odds ratios were not 
heterogenous (p<0.05), the odds ratios could not be combined and effect measure 
modification between the variables was considered to be present. A stratified analysis, with 
separate logistic regression models for each group, might then be indicated.  
 
2.10 Ethics approval 
This secondary data analysis was approved by the Human Research Ethics Committee 
(Medical) of the University of Witwatersrand on 28/11/2008 (Appendix E).  
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3. RESULTS 
 
3.1 General description of hospital admissions 
 
Using the dataset, a total of 39 879 children were identified as being enrolled on the study. 
The first patients were enrolled on 2 March 1998 and enrolment concluded on 29 
September 2000. Mean age at enrolment was 46 days (± SD 8.94), so on average the 
participants were 6 weeks or older at enrolment. The total study follow up period was from 
initial enrolment (first study visit) until 18 September 2005. After excluding admissions 
occurring over the age of 5 years and those within 2 weeks of a previous admission, there 
were 9108 admissions to the paediatric wards at CHBH over the study period, occurring in 
6328 patients.  Admissions included those to the four general admission wards, the short-
stay ward and the gastroenteritis unit (GEU). Median age at admission was 11.96 months 
(IQR 5.09-23.97 months, range 1.22-59.99).  
 
There were 2006 admissions with a primary or secondary diagnosis of gastroenteritis. Of 
these 57 were excluded as duration of diarrhoea was 14 days or longer, leaving a total of           
1949 admissions for acute gastroenteritis in 1761 participants. Twenty-one percent of all 
admissions were, therefore, due completely or in part to acute gastroenteritis. Of the 1949 
acute gastroenteritis admissions, 609 (31.25%) occurred in those < 6 months of age (> 6 
weeks), 635 (32.58%) in those aged 6-11.9 months, 473 (24.27%) in those between 1 and 2 
years and 232 (11.90%) in those between 2 and 5 years. The majority of acute 
gastroenteritis admissions (88.90%) occurred in children less than 2 years, with 63.83% in 
those less than one year of age. Figure 1 shows the number of admissions for acute 
gastroenteritis as a proportion of total hospital admissions, stratified by age group. In those 
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under 6 months of age 23.05%  of total admissions in that age group were due to acute 
gastroenteritis, 32.99% in those aged between 6 and 12 months, 20.86% in those aged 
between 1 and 2 years and 10.20% in those aged between 2 and 5 years. 
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Figure 1: Number of admissions over the study period due to acute gastroenteritis as a 
proportion of total hospital admissions, stratified by age group. 
 
Of the 1761 participants admitted with acute gastroenteritis, 156 had multiple admissions 
for acute gastroenteritis. Eighty-four (53.85%) of these children were HIV-infected. Those 
children with more than one admission for acute gastroenteritis were 4.97 (CI95% 2.85, 
5.81) times more likely to be HIV-infected than those with only one admission for acute 
gastroenteritis. 
 
Of the 1949 admissions for acute gastroenteritis, 504 (25.86%) occurred in children found 
to be HIV-infected , with 29.56% of those under 6 months testing HIV-positive, 24.57% of 
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those between 6 and 12 months, 23.26% between 1 and 2 years, and 25.0% of those 
between 2 and 5 years. Figure 2 shows the proportion of admissions due to acute 
gastroenteritis (stratified by age group) of children who were HIV-infected, HIV-
uninfected and those in whom HIV status was unknown. HIV status was not known in 
12.52% of total participants. The age group with the most patients with unknown HIV 
status was those between 2 and 5 years, with 34.05% not tested for HIV. In those admitted 
in the general paediatric wards 247/562 (43.95%) were HIV-infected compared to 
251/1127 (22.27%) in the short-stay ward / GEU. The HIV status was unknown in 
208/1335 (15.58%) of those admitted to the short-stay ward compared to 31/593 (5.23%) 
in the general wards. 
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Figure 2: HIV infection status of children hospitalised due to acute gastroenteritis, 
stratified by age group. 
 
 
 30
3.2 Seasonality of admissions 
 
The number of admissions for acute gastroenteritis as well as the total number of 
admissions during the study period were stratified by month of admission and depicted 
graphically over the study follow up time. Figure 3 shows seasonal trends over time for 
children under 5 years of age. There appears to be a peak in acute gastroenteritis 
admissions in March to May in the years 1999, 2000 and 2001. The initiation of these 
peaks are mirrored in the graph for total admissions, however, total admissions then remain 
high until a dip in December, reflecting the increased winter admissions due to respiratory 
tract infections. The peaks in acute gastroenteritis admissions are most apparent in those 
aged under two years. Admission numbers decrease with increasing time as the cohort is 
aging and the five year individual follow up period stretches over a total follow up period 
of eight years.  
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Figure 3: Distribution of total admissions and acute gastroenteritis admissions over time 
in children under five years of age.
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3.3 Presenting symptoms on admission 
 
Common symptoms at admission included fever, loss of weight, refusal to feed, vomiting, 
and diarrhoea (Figure 4). Sixty-four percent of children admitted with acute gastroenteritis 
presented with both vomiting and diarrhoea. There was no significant difference in the 
proportion presenting with fever, vomiting or diarrhoea (p=0.12, p=0.19 and p=0.13 
respectively) between HIV-infected and uninfected children. HIV-infected children were 
more likely to present with refusal to feed and loss of weight (p<0.001 for both).  
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Figure 4: Presenting symptoms on admission for acute gastroenteritis by HIV status. 
(Numbers of children presenting with each symptom are enumerated on the bars. 
Denominators may be different to the total number due to missing data. Denominators 
reflect number in whom data were available.) 
 
 
The mean duration of diarrhoea was 3.05 days (±1.86) with duration of diarrhoea 
significantly longer in HIV-infected children compared to HIV–uninfected children (3.40 
and 2.99 days respectively, p<0.001). Seizures were more common in HIV-uninfected 
children with 5.56% presenting with this symptom compared to 1.83% in the HIV-infected 
(p=0.001).  
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3.4 Characteristics of children admitted with an episode of acute gastroenteritis 
 
The characteristics of children admitted with an episode of acute gastroenteritis are shown 
in Table 1.  This includes total acute gastroenteritis admissions as well as characteristics 
stratified by HIV infection status. The median age at admission was 9.06 months, with 
50% of admissions occurring in children between 5.09 and 15.50 months of age. There was 
no significant difference in median age between HIV-infected and HIV-uninfected 
children. Fifty-four percent of those admitted were male, with no significant difference 
between those HIV-infected and uninfected. Mean gestational age was 38.08 weeks 
(±2.06) with 12.65% of children having a gestational age of < 37 weeks at birth and 
defined as preterm. Gestational age did not differ significantly when comparing HIV-
infected and HIV–uninfected children (p=0.52), but 15.51% of HIV-infected children had 
been born preterm compared to 12% of HIV-uninfected children (p=0.05). 
 
A large proportion of children were admitted to the short-stay ward or GEU and only 
30.76% were admitted in the general paediatric wards. HIV-infected children were almost 
three times more likely to be admitted to a general ward than uninfected children (OR 2.74; 
CI95% 2.19, 3.42). Just under thirty-three percent of children were classified as 
malnourished on admission and 13.32% were clinically assessed as being severely 
dehydrated.  HIV-infected children were eight times more likely to be malnourished at the 
time of admission (OR 8.39; CI95% 6.60, 10.69) and 1.6 times more likely to be assessed as 
having severe dehydration (OR 1.56; CI95%1.15, 2.10). A co-diagnosis of LRTI and acute 
gastroenteritis was also more likely in HIV-infected children, with 31.75% of these 
children presenting with acute gastroenteritis as well as a LRTI on admission diagnosis, 
compared to 9.83% in uninfected children (OR 4.27; CI95% 3.24, 5.63). 
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Table 1: Characteristics of children hospitalised with an episode of acute gastroenteritis – total numbers and stratified by HIV infection status. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IQR – interquartile range, LRTI – lower respiratory tract infection 
* Only includes those who had an HIV result available. Those with an equivocal or unknown HIV status were included in the total number but 
not included in the comparison between HIV-infected and HIV-uninfected children.  
Denominators in each cell may be different to total number HIV-infected and –uninfected due to missing data. Denominators reflect number in 
whom data were available.  
# Excluding the following contaminants: Bacillus, Coagulase negative Staphylococcus, Corynebacterium, Micrococcus or Propionibacterium.
Characteristic 
Total 
n=1949 
HIV Uninfected *
n= 1201 
HIV Infected * 
n=504 
Odds Ratio (CI95%) P value
Median age in months  (IQR) 9.06 (5.09, 15.50) 8.97 (5.12, 14.19) 8.57 (4.57, 14.77) - 0.75 
Male Sex (%) 1060/1947 (54.44) 649/1200 (54.08) 275/503 (54.67) 1.02 (0.83, 1.27) 0.82 
Preterm (%) 246/1944 (12.65) 144/1200 (12.00) 78/503 (15.51) 1.35 (0.99, 1.83) 0.05 
General ward (%) 593/1928 (30.76) 315/1191 (26.45) 247/498 (49.60) 2.74 (2.19, 3.42) <0.001 
Malnutrition (%) 642/1949 (32.94) 254/1201 (21.15) 349/504 (69.25) 8.39 (6.60, 10.69) <0.001 
Level of dehydration n=1885 n=1174 n=488   
≤2.5% 1107 (58.73) 713 (60.73) 235 (48.16) 0.60 (0.48, 0.75) <0.001 
>2.5%-≤5% 527 (27.96) 316 (26.92) 165 (33.81) 1.39 (1.10, 1.75) 0.005 
>5%-≤7.5% 115 (6.10) 64 (5.45) 45 (9.22) 1.76 (1.16, 2.66) 0.005 
>7.5% 136 (7.21) 81 (6.90) 43 (8.81) 1.30 (0.86, 1.94) 0.177 
Severe Dehydration (%) 251/1885 (13.32) 145/1174 (12.35) 88/488 (18.03) 1.56 (1.15, 2.10) 0.002 
Co-diagnosis of LRTI (%) 282/1949 (14.47) 118/1201 (9.83) 160/504 (31.75) 4.27 (3.24, 5.63) <0.001 
Bacteraemia (%) # 77/855 (9.01) 28/480 (5.8) 45/293 (15.36) 2.93 (1.74, 5.00) <0.001 
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3.5 Laboratory indicators 
 
Laboratory indicators were not available in all patients. Most of the patients admitted to the 
short-stay ward did not have any investigations done during the admission. A white cell 
count (WCC) was only available in 223 (11.44%) patients with an episode of acute 
gastroenteritis. Median WCC was 12.5 (IQR 9.3, 17.9) x109/ l. Platelets were measured in 
595 (30.53 %) with a mean platelet count of 384 (SD ±175) x109/ l. C-reactive protein, an 
acute inflammatory marker, was available in 590 (30.27%) with a median value of 16 (IQR 
4, 54) mg/l. There was a discrepancy between the number of WCC and platelet counts 
available. A full blood count usually reports both WCC and platelet count, however, in the 
dataset there were more platelet results than WCC results.  
 
Blood cultures were done in 855 (43.87%) patients and 665 (77.78%) of these were 
reported as negative. Of the 190 remaining blood cultures where an organism grew, 113 
grew an organism considered likely to be a contaminant i.e. Bacillus, Coagulase negative 
Staphylococcus, Corynebacterium, Micrococcus or Propionibacterium. The remaining 77 
were considered to have cultured a significant pathogen and the following were isolated: 
Escherichia coli (n=20), Streptococcus pneumoniae (n=14), Salmonella spp (n=10), 
Staphylococcus aureus (n=7), Haemophilus influenzae (n=4), Campylobacter spp (n=2), 
Shigella spp (n=1) and other pathogens (n=19). HIV-infected children were more likely to 
have a significant positive blood culture on admission than HIV-uninfected children (OR 
2.93; CI95% 1.74, 5.00; Table 1). 
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3.6 Incidence rates of acute gastroenteritis 
 
The incidence of acute gastroenteritis is shown in Table 2, with a total incidence in the 
cohort of 10.13 (CI95% 9.68, 10.58) episodes of acute gastroenteritis per 1000 person years. 
Incidence rates were also stratified by age group. The incidence was highest in those aged 
between 6 weeks and 6 months, with a slightly lower incidence in those aged between 6 
and 12 months compared to the first six months of life. Incidence decreased with 
increasing age and was lowest in those between 2 and 5 years of age. There was no 
difference in the incidence rate in the placebo group (10.03; CI95% 9.40, 1.07 per 1000 
person years) compared to those receiving the PCV (10.18; CI95% 9.56, 10.84; Incidence 
rate ratio (IRR) 0.98; CI95% 0.90, 1.08). 
 
Table 2: Incidence rates per 1000 person years (95% confidence interval) of acute 
gastroenteritis episodes among children under 5 years of age, stratified by age group. 
 
Age group 
Number of 
acute GE 
episodes 
Total person 
years in age 
interval 
Incidence rate (CI95%) 
(per 1000 person years) 
6 weeks - 6 
months 609 14840 41.04 (37.90, 44.35) 
6 - 11.9 months 635 19782 32.10 (29.69, 34.65) 
12 - 23.9 months 473 39498 11.97 (10.93, 13.10) 
24 – 59.9 
months 232 118334 1.96 (1.72, 2.23) 
        Total  1949 192454 10.13 (9.68, 10.58) 
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Incidence risk of acute gastroenteritis stratified by HIV infection status is shown in Table 
3. These results are calculated per 1000 persons over the age interval, not per 1000 person 
years, and are thus not comparable across age categories. The total incidence of acute 
gastroenteritis over the five year study period was 5.42 times (CI95% 4.89, 6.01) higher in 
those infected with HIV compared to that in HIV-uninfected children. The incidence was 
higher in the HIV-infected compared to the HIV-uninfected children across all age groups. 
Over the five year follow up period the excess occurrence of acute gastroenteritis among 
HIV-infected children attributable to their HIV infection was 171.56 (CI95% 153.09, 
190.04) per 1000 persons.
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Table 3: Incidence rates per 1000 persons per time period (95% confidence interval) of acute gastroenteritis episodes among children under 5 
years of age, stratified by age group and HIV infection status. 
 
 HIV-Infected HIV-Uninfected  
Age group 
Number of 
acute GE 
episodes 
Number 
of persons 
Incidence risk 
per 1000 persons 
per time period 
Number of 
acute GE 
episodes 
Number 
of persons 
Incidence risk 
per 1000 persons 
per time period 
Relative risk Attributable risk 
6 weeks- 6 
months 180 2468 
72.93  
(62.98, 83.91) 429 37279 
11.51  
(10.45, 12.64) 
6.33  
(5.30, 7.56) 
61.43  
(50.72, 72.14) 
6 - 11.9 
months 156 2319 
67.27  
(57.41, 78.24) 479 37247 
12.86  
(11.74, 14.06) 
5.23  
(4.34, 6.28) 
54.41  
(43.79, 65.03) 
12 - 23.9 
months 110 2264 
48.59  
(40.10, 58.27) 363 37229 
9.75  
(8.78, 10.80) 
4.98  
(3.99, 6.18) 
38.84  
(29.70, 47.97) 
24 – 59.9 
months 58 2230 
26.01  
(19.81, 33.49) 174 37214 
4.68 
 (4.01, 5.42) 
5.56  
(4.06, 7.53) 
21.33  
(14.61, 28.07) 
Total 504 2396 210.35  (194.18, 227.23) 1445 37254 
38.79  
(36.85, 40.80) 
5.42  
(4.89, 6.01) 
171.56  
(153.09, 190.04) 
 
 Attributable risk = risk difference 
See Appendix D for tables illustrating the estimations for the denominators.
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3.7 Risk factors for mortality 
 
There were 68 deaths among those admitted with acute gastroenteritis during the follow up 
period, so mortality was 3.49%. The month of the year in which the admission occurred 
did not have any significant effect on mortality (p=0.63 for trend), nor did the year of 
admission have any significant effect on mortality (p=0.27 for trend). There was no 
difference in mortality between those who received the pneumococcal conjugate vaccine 
and those that received placebo (p=0.50).  
 
The results of a univariate analysis of risk factors associated with death are shown in Table 
4. Age (in months) was significantly associated with death (p=0.004), and the odds of 
dying decreased by 5% (CI95% 2, 8%) for each month increase in age. Age was also 
considered categorically (not shown), with age < 6 months (but >6 weeks) as the reference 
age group. Children in age groups 6-11.9 months, 12-23.9 months and 24-59.9 months 
were all less likely to die than those aged < 6 months (OR 0.44 CI95%: 0.24, 0.79; OR 0.41 
CI95%: 0.21, 0.81; OR 0.21 CI95%: 0.06, 0.68 respectively). However, these confidence 
intervals were wide due to the small numbers in some of the cells. Age was thus re-
categorised as a dichotomous variable comparing those aged 6 weeks to 6 months  to those 
aged 6 months or older. Those aged under 6 months were 2.57 times (CI95% 1.53, 4.31) 
more likely to die than those aged 6 months or above.  
 
Sex, prematurity and duration of diarrhoea preceding hospitalisation were not significantly 
associated with death. The odds of dying were increased in those presenting with 
malnutrition (OR 6.55; CI95% 3.68, 12.18) and HIV-infection (OR 8.32; CI95% 4.52, 16.15). 
Compared to the reference group (those with dehydration ≤2.5%) children with >2.5% but 
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≤5%, were not more likely to die (OR 1.10; CI95% 0.53, 2.30). However, children 
presenting with dehydration of >5% but ≤7.5%, and those with >7.5% dehydration were 
more likely to die compared to the reference group (OR 3.87; CI95% 1.67, 8.94 and OR 
11.08; CI95% 5.98, 20.5 respectively). Once again the confidence intervals were large due to 
small numbers in cells after categorising the variable. Dehydration was, thus, considered as 
a dichotomous variable with the latter two levels of dehydration combined and considered 
as severely dehydrated, and the former as not severely dehydrated. The odds of dying were 
increased in those presenting with dehydration >5% (severe dehydration) compared to 
those who were less than 5% dehydrated (OR 7.31; CI95% 4.24, 12.58).  
 
Table 4: Clinical risk factors for death among children hospitalised for acute 
gastroenteritis: univariate analysis. 
Risk factor Died n=68* 
Discharged 
n=1881* 
Unadjusted 
odds ratio CI95% p -value 
Age in months 
median (IQR) 
5.68 
(3.25 – 10.87) 
9.19 
(5.12 – 15.57) 0.95 0.92, 0.98 
0.004 
 
Age > 6 weeks 
< 6 months 36/68 (52.94) 573/1881 (30.46) 2.57 1.53, 4.31 <0.001 
Male Sex 
(%) 36/68 (52.94) 
1024/1879 
(54.50) 0.94 0.56, 1.58 0.80 
  Prematurity 7/68 (10.29) 239/1876 (12.74) 0.79 0.30, 1.75 0.55 
Duration of 
diarrhoea at 
admission (%) 
3.47 (± 2.17) 3.04 (± 1.84) 1.11 0.98, 1.28    0.10 
Malnutrition 
(%) 51/68 (75.00) 591/1881 (31.42) 6.55 3.68, 12.18 <0.001 
HIV infection 
(%) 48/63 (76.19) 456/1642 (27.77) 8.32 4.52, 16.15 <0.001 
Severe 
dehydration 
(%) 
32/64 (50.00) 219/1821 (12.03) 7.31 4.24, 12.58 <0.001 
Bacteraemia 13/58 (22.41) 64/797 (8.03) 3.31 1.55, 6.63     <0.001 
Co-diagnosis 
of LRTI (%) 31/68 (45.59) 
251/1881  
(13.34) 5.44 3.19, 9.18 <0.001 
*Denominators in each cell may be different to total number HIV-infected and –uninfected 
due to missing data. Denominators reflect number in whom data were available. 
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A concomitant diagnosis of LRTI was significantly associated with death (OR 5.44; CI95% 
3.19, 9.18), and those with significant bacteraemia (excluding contaminants) also had 
increased odds of dying (OR 3.31; CI95% 1.55, 6.63).   
 
For the multivariate analysis variables were introduced into the logistic regression model 
one by one using forward selection, and improvement in the model was assessed by 
significant improvement in the -2 log likelihood ratio. Age and level of dehydration were 
considered as dichotomous variables as described above. The final multiple logistic 
regression model included age, presence of malnutrition, severe dehydration, HIV 
infection, and concomitant diagnosis of LRTI. Sex, prematurity and duration of diarrhoea 
were not included as these were not significantly associated with death in the univariate 
analysis and when included in the logistic regression model did not improve the fit of the 
model. Bacteraemia was not included in the model due to the number of children in which 
a culture was not done. The results of the multivariate analysis are shown in Table 5. 
 
Table 5: Clinical risk factors for death among children hospitalised for acute 
gastroenteritis: multivariate analysis 
 
Risk factor Unadjusted OR Adjusted OR * 
Age > 6 weeks < 6 
months 2.57 (1.53, 4.31) 2.11 (1.21, 3.69) 
Malnutrition 6.55 (3.68, 12.18) 2.17 (1.11, 4.23) 
Severe dehydration 7.31 (4.24, 12.58) 5.78 (3.23, 10.33) 
HIV Infection 8.32 (4.52, 16.15) 3.99 (2.04, 7.81) 
Co-diagnosis of 
LRTI 5.44 (3.19, 9.18) 3.57 (1.99, 6.42) 
 
* Adjusted OR: OR after adjusting for age, malnutrition, severe dehydration, HIV infection 
and concomitant diagnosis of lower respiratory tract infection (LRTI). 
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After adjustment for other factors included in the model, associations between the 
variables and the odds of dying were diminished but remained significant. Those children 
greater than 6 weeks to less than 6 months were 2.11 times (CI95% 1.21, 3.69) more likely 
to die than those 6 months and older. HIV-infected children were almost four times more 
likely to die during the admission than HIV-uninfected children, those presenting with 
malnutrition were approximately twice as likely to die compared to those classified as 
adequately nourished. The odds of dying were 3.57 (CI95% 1.99, 6.42) times greater in 
those with a concomitant diagnosis of LRTI and 5.78 times (CI95%3.23, 10.33) greater in 
those presenting with severe dehydration. 
 
The possibility of effect measure modification was investigated in the logistic regression 
model. HIV infection was an effect modifier when investigating the association between 
malnutrition and mortality. When stratifying the association between malnutrition and 
death by HIV status, the odds ratios obtained were not homogenous with an OR of 1.77 
(CI95 0.86, 3.66) for those HIV-infected compared to 7.72 (CI95% 2.59, 23.01) in the HIV-
uninfected (Mantel-Haenszel method, test for homogeneity of ORs p=0.02). The combined 
OR (2.61) was also different from the crude OR (6.55). This suggests both confounding of 
the relationship between malnutrition and death by HIV infection as well as possible effect 
modification. The addition of a multiplicative interaction term (HIV status x malnutrition) 
into the model was also significant. A stratified logistic regression model may, therefore, 
have been indicated with two separate models generated, one for HIV-infected and one for 
HIV-uninfected children. The adjusted OR for malnutrition in the model for the HIV-
infected was 1.34 (CI95% 0.63, 2.89) and in the model for the HIV-uninfected the adjusted 
OR was 4.60 (CI95% 1.48, 14.34). In the uninfected, malnutrition was a significant risk 
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factor for death in those with acute gastroenteritis, while this association was not 
significant in the HIV-infected children.  
 
The reason for this may lie in the classification of malnutrition used. In this classification 
those children under 80% of expected weight were classified as under-weight for age. HIV 
leads to low weight for age by pathways other than malnutrition, and HIV-infected 
children may be misclassified as malnourished (under-weight for age or marasmic) in the 
absence of true malnourishment. The HIV disease process itself is accounting for the lower 
weight in these children. However, the stratified model for the HIV-uninfected children led 
to small numbers in some of the cells leading to large standard errors and wide confidence 
intervals. It was finally decided not to stratify and thus one logistic regression model was 
presented (Table 5) with HIV-infected and uninfected children included in one model.  
 
3.8 Risk factors for prolonged hospitalisation 
 
The median duration of hospitalisation was 2 days (IQR 1-4 days). There were 1233 
(63.26%) children admitted with an acute gastroenteritis episode who had a duration of 
hospitalisation of 2 days or less, and 716 (36.74%) with duration of hospitalisation greater 
than the median of 2 days. There was no difference in the duration of hospitalisation 
between those receiving PCV and those receiving placebo (p=0.94). The median duration 
of hospitalisation in HIV-uninfected children admitted with acute gastroenteritis was 2 
days (IQR 1-3) compared to 3 days (IQR 2-7) in the HIV-infected children with acute 
gastroenteritis (p<0.001). 
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The results of a univariate analysis of risk factors associated with hospitalisation greater 
than 2 days are shown in Table 6. Age (in months) was significantly associated with 
prolonged hospitalisation (p<0.001). Age was also considered categorically (not shown), 
with age < 6 months (but >6 weeks) as the reference age group. Children in age groups 6-
11.9 months, 12-23.9 months and 24-59.9 months were all less likely to be hospitalised for 
longer than 2 days compared to those aged < 6 months (OR 0.55 CI95%: 0.43, 0.69; OR 
0.44 CI95%: 0.34, 0.57; OR 0.41 CI95%: 0.30, 0.27 respectively). Age was re-categorised as 
a dichotomous variable comparing those aged less than 6 months (> 6 weeks) with the 
older age categories combined. Those aged less than 6 months were 2.07 times (CI95% 1.69, 
2.53) more likely to be hospitalised for longer than 2 days compared to those aged 6 
months or older. Sex was not significantly associated with death (p=0.31). Those who were 
born at a gestational age of less than 37 weeks were at a slightly increased risk of 
prolonged hospitalisation (OR 1.33; CI95% 1.00, 1.76, p=0.04). 
 
The odds of prolonged hospitalisation were increased in those presenting with malnutrition 
(OR 3.78; CI95% 3.08, 4.63) and HIV-infection (OR 3.00; CI95% 2.41, 3.74). Compared to 
the reference group, those with dehydration ≤2.5%, children with >2.5% but ≤5%, were 
more likely to have a prolonged hospitalisation (OR 1.68; CI95% 1.34, 2.09). Children 
presenting with dehydration of >5% but ≤7.5%, and those with >7.5% dehydration were 
much more likely to be hospitalised for longer than 2 days compared to the reference group 
(OR 14.90; CI95% 8.86, 25.08 and OR 12.28; CI95% 7.80, 19.33). But once again the 
confidence intervals were large due to small numbers in cells after categorising the 
variable. Dehydration was, thus, considered as a dichotomous variable with the latter two 
levels of dehydration combined and considered as severely dehydrated, and the former as 
not severely dehydrated. The odds of a prolonged hospitalisation were increased in those 
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presenting with dehydration >5% (severe dehydration) compared to those who were less 
than 5% dehydrated (OR 11.20; CI95% 7.87, 16.18). A concomitant diagnosis of LRTI was 
significantly associated with prolonged hospitalisation (OR 3.47; CI95% 2.65, 4.55), and 
those with significant bacteraemia (excluding contaminants) had increased odds of a 
prolonged hospitalisation (OR 2.49; CI95% 1.38, 4.70).   
 
Table 6: Clinical risk factors for prolonged hospitalisation (> 2 days) among children 
hospitalised for acute gastroenteritis: univariate analysis. 
 
Risk factor > 2 days n=716 
≤ 2 days 
n=1233 
Unadjusted 
OR 95% CI p -value 
Age in months 
median (IQR) 
7.52 
(3.96, 13.03) 
9.79 
(5.94, 17.58) 0.98 0.97, 0.98 <0.001 
Age > 6 weeks 
< 6 months 296/716 (41.34) 313/1233 (25.39) 2.07 1.69, 2.53   <0.001 
Male Sex (%) 400/715 (55.94) 660/1232 (53.57) 1.10 0.91, 1.33 0.31 
Prematurity 105/715 (14.69) 141/1229 (11.47) 1.33 1.01- 1.76   0.04 
Malnutrition 
(%) 370/716 (51.68) 272/1233 (22.06) 3.78 3.08, 4.63 <0.0001 
HIV infection 
(%) 294/676 (43.49) 210/1029 (20.41) 3.00 2.41, 3.74 <0.0001 
Severe 
dehydration 
(%) 
208/701 (29.67) 43/1184 (3.63) 11.20 7.87, 16.18 <0.0001 
Co-diagnosis 
of LRTI (%) 176/716 (24.58) 106/1233 (8.60) 3.47 2.65, 4.55 <0.0001 
Bacteraemia 61/532 (11.47) 16/323 (4.95) 2.49 1.38, 4.70   0.001 
 
 
For the multivariate analysis variables were introduced into the logistic regression model 
one by one using forward selection, and improvement in the model was assessed by 
significant improvement in the -2 log likelihood ratio. Age and level of dehydration were 
considered as dichotomous variables.  
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The final multiple logistic regression model included age, presence of malnutrition, severe 
dehydration, HIV infection, and concomitant diagnosis of LRTI. Sex and bacteraemia were 
not included in the model as these variables were not significantly associated with 
prolonged hospitalisation in the univariate analysis and when included in the logistic 
regression model did not improve the fit of the model. Prematurity, although significantly 
associated with prolonged hospitalisation in the univariate analysis, did not significantly 
improve the model and was not included in the final model. The results of the multivariate 
analysis are shown in Table 7. 
 
Table 7: Clinical risk factors for prolonged hospitalisation among children hospitalised 
for acute gastroenteritis: multivariate analysis 
 
Risk factor Unadjusted OR Adjusted OR * 
Age > 6 weeks < 6 
months 2.07 (1.69, 2.53) 1.67 (1.31, 2.12) 
Malnutrition 3.78 (3.08, 4.63) 2.32 (1.80, 3.00) 
Severe dehydration 11.20 (7.87, 16.18) 11.58 (7.82, 17.13) 
HIV Infection 3.00 (2.41, 3.74) 1.81 (1.38, 2.38) 
Co-diagnosis of 
LRTI 3.47 (2.65, 4.55) 2.80 (2.06, 3.79) 
 
* Adjusted OR: OR after adjusting for age, malnutrition, severe dehydration, HIV infection 
and concomitant diagnosis of lower respiratory tract infection (LRTI). 
 
After adjustment for other factors included in the model, associations between the 
variables and the odds of being hospitalised for longer than 2 days are shown in Table 7. 
Those children greater than 6 weeks (on average) but < 6 months were 1.67 times (CI95% 
1.31, 2.12) more likely to have prolonged hospitalisation than those 6 months and older. 
HIV-infected children were almost twice as likely to have a prolonged hospitalisation as 
HIV-uninfected children, and those presenting with malnutrition were almost 2.32 times as 
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likely to have a prolonged hospitalisation compared to those classified as adequately 
nourished. The odds of remaining in hospital for longer than 2 days were 2.80 (CI95% 2.06, 
3.79) times greater in those with a concomitant diagnosis of LRTI and 11.58 times (CI95% 
7.82, 17.13) greater in those presenting with severe dehydration. 
 
The possibility of effect measure modification was investigated in the logistic regression 
model. HIV infection was an effect modifier when investigating the association between 
dehydration and prolonged hospitalisation. When stratifying the association between 
dehydration and prolonged hospitalisation by HIV status, the odds ratios obtained were not 
homogenous with an OR of 4.91 (CI95% 2.59, 9.3) for those HIV-infected compared to 
17.42 (CI95% 10.29, 29.49) in the HIV-uninfected (Mantel-Haenszel method, test for 
homogeneity of ORs p=0.002). The addition of a multiplicative interaction term (HIV 
status x dehydration) into the model was also significant. A stratified logistic regression 
model may, therefore, have been indicated with two separate models generated, one for 
HIV-infected and one for HIV-uninfected children. The adjusted OR for dehydration in the 
model for the HIV-infected was 5.31 (CI95% 2.79, 10.09) and in the model for the HIV-
uninfected the adjusted OR was 16.33 (CI95% 10.03, 26.57). It was finally decided not to 
stratify due to the large standard errors and confidence intervals in this model, and thus one 
logistic regression model was presented (Table 7) with HIV-infected and uninfected 
children included in one model.  
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4. DISCUSSION 
 
The aim of this project was to determine the burden of disease caused by severe acute 
gastroenteritis and the influence of age and HIV infection status on incidence rates, as well 
as to identify risk factors associated with death and prolonged hospitalisation in children 
admitted with acute gastroenteritis. Acute gastroenteritis was identified as an important 
cause of admission to the CHBH with 21% of the total admissions over the study period 
due totally or partly to acute gastroenteritis. HIV infection remains a major challenge to 
clinicians with just over 25% of children admitted with acute gastroenteritis being 
identified as HIV-infected despite only an estimated 6.47% of the enrolled cohort being 
HIV-infected. Incidence of severe acute gastroenteritis was highest in the under 6 month 
age group, with almost 90% of admissions occurring in those under 2 years of age. The 
incidence rate was five times greater in HIV-infected children compared to those children 
who were HIV-uninfected. Those presenting with malnutrition, severe dehydration, HIV 
infection and a concomitant diagnosis of LRTI were more likely to die during the 
hospitalisation, and more likely to be hospitalised for longer than two days compared to 
those children who did not have these risk factors,. However, in considering the findings of 
this study there are several limitations to consider.  
 
The original study was primarily a vaccine efficacy trial with invasive pneumococcal 
disease and pneumonia as the measured outcomes, and the data collected was not done 
with the present study objectives in mind. There are some risk factors or potential 
confounders which should have been considered for inclusion in the analysis, yet were not 
measured and could not be adjusted for in the multivariate analysis. Information on 
maternal education and household income or socioeconomic status was not collected. Non 
breastfeeding has been identified risk factor for death from acute gastroenteritis (39) yet a 
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feeding history was not available in the dataset and could not be investigated as a potential 
risk factor for death or prolonged hospitalisation, or adjusted for in the logistic regression 
model. In an urban area with high HIV prevalence breastfeeding is generally discouraged 
in HIV-infected mothers, and there is a possibility that these infants are at greater risk of 
diarrhoeal disease especially in the first few months of life. 
 
 Low birth weight has been associated with hospitalisation for acute gastroenteritis (34, 
38), yet birth weight was only available in a very small proportion  (169/1949, 8.7%) of the 
participants and, thus, this risk factor could not be adjusted for in the multivariate analysis. 
Gestational age was available on all participants and was used as a proxy for birth weight. 
Birth weight is correlated with gestational age, and those infants born prematurely tend to 
have a lower birth weight. However, estimation of gestational age may be inaccurate if the 
date of the last menstruation is not known, early estimation of gestational age by sonar is 
not done and gestation is only determined late in the pregnancy. Birth weight is a more 
accurate and verifiable measure as it is measured at birth in all children and the 
measurement tool (a baby scale) can be validated. So although gestational age at birth was 
available, birth weight would have been preferable.  
 
More detailed data on duration of vomiting and maximum number of episodes of diarrhoea 
and vomiting in a 24-hour period was needed in order to calculate a severity score. A score 
was not applied in this analysis to grade the severity of episodes, as outlined by Vesikari 
(35), as some pertinent data was not available.  
 
The diagnosis of malnutrition could be made from weight-for-age criteria in the majority 
of patients (97%) and diagnosis of marasmus or kwashiorkor by a hospital physician was 
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used if no weight-for-age measure was available. Physician diagnosis is more subjective as 
there may be differences in the way hospital physicians record a diagnosis of malnutrition. 
Weight was measured on admission to the ward, and was not adjusted for the level of 
dehydration present. Acute gastroenteritis presents with dehydration which can cause acute 
weight loss. Some of the participants may have been misclassified as having malnutrition, 
as the corrected weight (after rehydration) may have been slightly higher, and may no 
longer have met the criteria (< 2 SD weight-for-age) for malnutrition. There was also the 
possibility of falsely classifying ex-premature infants as being malnourished when using 
their chronological age. This may have overestimated the number of participants classified 
as having malnutrition on admission, and thus overestimated the true prevalence of 
malnutrition. However, this is likely to be non-differential misclassification and would 
cause any estimated association to be biased towards the null. The percentage dehydration 
on admission needed to be considered, and the admission weight corrected in order to 
minimise misclassification. The corrected age in ex-premature infants should have been 
used in order to classify their nutritional status more accurately. Stunting may be 
considered as a more accurate measure.  
 
HIV results were not available for any of the participants in the cohort who were not 
hospitalised, and an estimated HIV prevalence was used based on certain assumptions on 
maternal HIV prevalence and transmission of HIV. These assumptions may lead to an 
inaccurate estimate of the true incidence of acute gastroenteritis based on HIV infection 
status. For incidence calculations, those with an unknown HIV result were considered to be 
HIV-uninfected. There was thus a risk of misclassification as some of these may actually 
have been HIV-infected. However, any misclassification of children as HIV-uninfected 
who were truly HIV-infected would have led to an underestimation of the true incidence of 
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acute gastroenteritis in the HIV-infected cohort. HIV results were also not available in all 
hospitalised participants with acute gastroenteritis (missing in 12.52%), and excluding 
those without a known result in the comparative analysis may have lead to incorrect 
measures of association between risk factors and outcomes.  
 
Although rotavirus infection did not affect HIV viral load or CD4 counts in a Malawian 
study (50), the numbers in the study were small. With the data available in this analysis, 
the effect of diarrhoea on CD4 counts and viral loads could not be investigated.  
 
There were no stool samples collected on admission and so no stool identification of 
pathogens was possible. As a result the true proportion of severe acute gastroenteritis 
caused by rotavirus could not be determined. Inferences can be made based on data from 
surveillance programmes studies, where rotavirus was the most important cause of severe 
acute gastroenteritis accounting for approximately 40% of hospitalisations for diarrhoea in 
children less than 5 years (12). Results from Dr George Mukhari hospital in Gauteng found 
24% of patients presenting with diarrhoea to be rotavirus positive, but included both in-
patients and out-patients. Rotavirus gastroenteritis was more frequently detected among in-
patients (personal communication Dr Seheri, Medunsa).  
 
There were also limitations related to the original study design. There was no active follow 
up of participants, only passive surveillance of hospitalisations of study participants. 
Participants may have moved from the area or died at home, and thus no longer be 
contributing to the total follow up time, yet as this information was not available, it was 
assumed that these participants had contributed the full 5 years of follow up time. This 
would have led to underestimation of incidence rates as the denominator would be inflated. 
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In a longitudinal birth cohort study conducted in Soweto, Johannesburg (Birth to Twenty), 
where children were followed up for more than 12 years, an average attrition rate of less 
than 3% per annum was found with most attrition occurring in the first two years of the 
study (51). 
 
Although CHBH is the referral hospital for all local clinics in Soweto, there is a chance 
that some participants may have consulted a private practitioner and had an admission at a 
private hospital. There is also the possibility that those with very severe acute 
gastroenteritis may have died in the community before arriving at the hospital. These cases 
would not have been identified as an episode of acute gastroenteritis and, therefore, not 
included in the numerator in incidence calculations but would have contributed to total 
person time. This would also lead to an underestimation of the number of admissions for 
severe acute gastroenteritis and the incidence rates.  
 
Deaths occurring at home after discharge would also not have been recorded as such, but 
as having been discharged. These deaths as well as those dying in the community prior to 
hospitalisation would lead to underestimation of mortality rates. Incidence of acute 
gastroenteritis varies with geographical area so these results may not be generalisable to 
other areas in South Africa.  
 
Despite these limitations the results of this secondary data analysis are consistent with 
findings from previous studies (13, 14, 19, 22, 23, 39). This study also provides unique 
information on disease burden estimates in HIV-infected children. The burden of disease 
due to severe acute gastroenteritis is greatest in young children, with incidence decreasing 
with increasing age. Eighty-nine percent of admissions for acute gastroenteritis occurred in 
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children less than 2 years of age, with 31% in those less than 6 months. This is similar to 
studies where rotavirus infection was shown to be most common in children under 2 years 
(13). Steele et al also showed the < 6 months age group to have a significant proportion of 
disease (14).  
 
In children over 2 years of age, the incidence falls dramatically and interventions should be 
focused in those under 2 years. Disease burden is high in those under 6 months of age, and 
these children had increased odds of dying and having a prolonged hospitalisation 
compared to older children,  which confirms the need for early introduction of a rotavirus 
vaccine, and early completion of vaccination course in developing countries. All the 
infants in this study were on average 6 weeks old so disease in neonates and preterm 
infants could not be investigated. Incidence calculations, therefore, only included those 
aged six weeks and upwards and we would have missed any admissions occurring prior to 
study enrolment. The incidence rate in the under six month age group may have been an 
underestimation if many hospitalisations for acute gastroenteritis occurred in the first six 
weeks of life. Admission criteria in the hospital may also have influenced the incidence 
calculated in those under six months of age. Children under six months may be selectively 
admitted by the admitting doctor when compared to an older child with a similar clinical 
picture and severity of diarrhoea. This might lead to inflation of the number of admissions 
in children under six months, and overestimate the incidence in this age group.  
 
The total burden of acute gastroenteritis (including mild and moderate acute 
gastroenteritis) could not be determined with the current study, as data were only available 
on those hospitalised with acute gastroenteritis. Less severe cases of acute gastroenteritis 
will present and be treated at local clinics or general practitioners, may not present to a 
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health care facility and just be treated at home. The economic burden of acute 
gastroenteritis extends beyond the costs associated with hospitalisation for severe acute 
gastroenteritis, and includes costs at primary health care level as well as the economic 
implications of parents who need to take time off work to look after their ill children.  
 
HIV infection remains a concern and is a frequent underlying illness, with just over a 
quarter of children admitted with acute gastroenteritis found to be infected with HIV. The 
percentage admitted in the general wards that were HIV-infected approached 45%. In a 
previous study conducted at CHBH, prevalence of HIV among all hospitalised children, 
not just those with acute gastroenteritis was 26.2%, with the same assumption that those 
with unknown status were uninfected (19). A similar study of diarrhoeal disease done at 
CHBH in 1996-1997 showed that 17.6% of children admitted for gastroenteritis were 
classified as HIV-infected, which is much lower than the proportion in our study and likely 
reflects the rising prevalence of HIV among attendees at antenatal clinics in the time 
between these studies and the greater proportion of children born that were HIV-infected. 
The Johnson et al study was conducted in the late 1990’s and the HIV infection rate was 
lower at that time (22). HIV prevalence at antenatal clinics was 22.8% in 1998 compared 
to 30.2 % in 2005 (45). HIV infection among children has been demonstrated to have 
increased the number of admissions in HIV-infected children (52).  
 
Although our data includes acute gastroenteritis from any cause, there does appear to be a 
peak in acute gastroenteritis admissions in March – May in 1999 to 2001. This is the 
period when most of the cohort was aged < 2 years and may reflect the increase due to 
rotavirus infections in the winter months. Unfortunately stool samples were not taken on 
any of the children and a definitive diagnosis of rotavirus disease could not be confirmed. 
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This would have enabled us to link the peak in acute gastroenteritis admissions to rotavirus 
infection. Data on seasonality from Dr George Mukhari Hospital between 2005 and 2008 
(Appendix F) shows increased rotavirus isolation (as a percentage of total diarrhoea) from 
March to August with a peak in May of each year.  
 
Concomitant diagnoses included HIV infection, malnutrition and lower respiratory tract 
infection which is in line with findings from other studies where infectious diseases and 
malnutrition have been identified as the most common reasons for admission in HIV-
infected children in developing countries (19, 53, 54). HIV-infected children were almost 
five times more likely than HIV-uninfected children to have multiple admissions for acute 
gastroenteritis. This once again highlights the extra burden of disease created by the HIV 
epidemic in this country, with multiple admissions and multiple illnesses diagnosed at each 
admission. Concurrent blood cultures were only submitted in just over 40% of those 
admitted for acute gastroenteritis. A high number of blood cultures grew suspected 
contaminants (113/190 [59.5%]). Concurrent significant bacteraemia was found in 9% of 
those in whom a blood culture was done. Bacteraemia has been found previously to be a 
significant risk factor for death (23). In our study the odds of dying and having a prolonged 
hospitalisation were increased in those with significant bacteraemia in the univariate 
analysis but this risk factor was not included in the multivariate analysis as many children 
had not had a blood culture performed. The presentation of invasive pneumococcal disease 
as severe gastroenteritis has been previously described and fourteen patients were found to 
have a blood culture positive for Streptococcus pneumoniae (55).  
 
The overall mortality rate was 3.49% among those admitted with acute gastroenteritis, 
which is lower than that found in a Natal study in 2001 where paediatric diarrhoeal 
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admissions had an inpatient mortality of 11% (23). However, this study included both 
acute and persistent cases of diarrhoea. These differing mortality rates may also reflect 
HIV infection prevalence, with prevalence in Natal being higher than in Gauteng, 
accounting for the increased mortality. HIV prevalence among antenatal clinic attendees in 
2001 was estimated at 33.5%  in KwaZulu Natal compared to 29.8%  in Gauteng (56). 
Mortality was only 2.2% in the acute gastroenteritis study from CHBH done in 1997 (22). 
Mortality rates may have risen from 1997 due to the increasing prevalence of HIV in 
Gauteng, accounting for increased mortality compared to Johnson et al’s study at CHBH 
(22). In my analysis, after adjustment, those who were HIV-infected were almost four 
times more likely to die than those who were HIV-uninfected, which is slightly higher than 
that found in the Natal gastroenteritis study (23).  
 
In children hospitalised for acute gastroenteritis there are likely to be many mediators and 
confounders in the association between HIV infection and mortality. Some of these have 
been accounted for in the analysis including malnutrition and infectious co-morbidities. 
But HIV infection in itself affects mortality and increased mortality occurs in HIV infected 
children irrespective of the admission diagnosis. Higher mortality in HIV infected children 
may be due to underlying HIV disease and concomitant infections. Acute gastroenteritis 
may not be the sole contributor to death as other aggravating factors may be present in 
these patients. HIV infection was also an important risk factor in predicting prolonged 
hospitalisation in children admitted with acute gastroenteritis and HIV-infected children 
were almost twice as likely to have a hospital stay of longer than 2 days.  
 
Prevention and treatment of HIV infection in children is an important way to decrease 
mortality and duration of hospitalisation. The rollout of ART is likely to have a profound 
 56
effect on mortality. ART suppresses HIV viral replication, allowing the immune system to 
reconstitute and to reverse immunodeficiency in children. This will lead to a decrease in 
paediatric hospitalisations and a decrease in morbidity and mortality in general (57). There 
is need for earlier diagnosis and treatment of HIV-infected children, as well as effective 
prevention of mother-to-child transmission of HIV infection.  
 
Malnutrition was identified as a significant risk factor for both mortality and prolonged 
hospitalisation as has been found in other studies (22, 39). The relationship between HIV 
and malnutrition is not a simple one. Effect measure modification was demonstrated 
between HIV status and malnutrition; even though data were presented without stratifying 
by HIV status. The aetiology of malnutrition is multifactorial and there is a complicated 
relationship between HIV and malnutrition making it difficult to determine independent 
contributions of HIV infection and malnutrition on mortality (23). There is an adverse 
effect of infections on the nutritional status as well as the greater susceptibility to infection 
of malnourished children, and the effects of malnutrition and infection combined are 
greater than the sum of the two. Nutritional deficiencies have effects on both humoral and 
cell-mediated immune function (58), and the interaction between HIV-infection and 
malnutrition is, therefore, also likely to be synergistic.  
 
HIV/AIDS is associated with both biological and social factors that may affect a child’s 
ability to consume and utilise food. Poor nutritional status and weight loss, common in 
HIV-infected children, is an important cause of morbidity and mortality in these children 
(59). In children < 60 months mortality was associated with decreasing weight-for-age Z 
score. About half of the children in a Zambian study of HIV-infected children on ART 
were more than 2 standard deviations below their expected weight for age, and this was 
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associated with higher mortality rates (60). Children receiving ART showed significant 
improvement in weight gain, as well as an increase in absolute CD4 cell count. A study 
from Natal, investigating a cohort of children receiving ART, showed that 96.6% had an 
increase in CD4% from baseline, and 73.8% had a significant increase in weight-for-age Z 
score after the first month following HAART (61).  
 
Malnourished children can be identified and can thus be targeted for early intervention, for 
example, initiation of antibiotics and nutritional therapies. Treatment of HIV infection will 
lead to an improvement in weight and both nutritional supplements and ART are likely to 
decrease malnutrition and, therefore, decrease mortality and duration of hospitalisation in 
children admitted with acute gastroenteritis. 
 
Severe dehydration was identified as a significant risk factor for both death and prolonged 
hospitalisation. Early identification of those with severe dehydration, together with early 
introduction of intravenous fluids is needed to prevent an adverse outcome in children 
admitted with acute gastroenteritis. Effect measure modification was demonstrated 
between HIV status and dehydration when investigating their effect on prolonged 
hospitalisation; even though data were presented without stratifying by HIV status. As with 
malnutrition there may be additional factors that need to be considered in the relationship 
between dehydration and prolonged hospitalisation in HIV-infected children. HIV-infected 
children were more likely to present with severe dehydration than uninfected children. The 
wellbeing of HIV-infected children relies on the mothers remaining alive and well and 
maternal death has been shown to have a negative impact on a child’s health (62, 63). 
There may be delays in bringing the child to a health care facility if the mother herself is 
not well and there may still be feelings of stigmatisation by the mother regarding the HIV 
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infection status of her and her child. Delays in accessing care may lead to the child being 
more severely dehydrated on admission. 
 
Concomitant infection with a lower respiratory tract infection was also a significant risk 
factor for both mortality and prolonged hospital stay in this analysis, which is once again in 
keeping with previous studies from South Africa (22, 23). Concurrent infections, especially 
lower respiratory tract infections, need to be identified on admission and treated 
appropriately with antibiotics early on to prevent the effects on mortality and prolonged 
hospitalisation.  
 
5. CONCLUSION 
 
Acute gastroenteritis is an important cause of hospitalisation, especially in children under 2 
years of age and those with concomitant HIV infection. Presence of malnutrition and 
severe dehydration on admission and a concomitant diagnosis of HIV infection and LRTI 
were all significant risk factors for both mortality in children admitted with an acute 
gastroenteritis episode, as well as predictors of a prolonged hospital stay. 
 
Interventions to prevent gastroenteritis and thus decrease mortality in children presenting 
with severe acute gastroenteritis, as well as to shorten the duration of the hospitalisation, 
can be targeted based on the abovementioned findings. Children with severe dehydration 
should be treated timeously with intravenous fluids. Underlying conditions, such as HIV 
infection, malnutrition and LRTI should be identified early and treated accordingly. HIV 
testing should be offered to all children and HIV-infected children should be referred for 
ART on discharge, if this has not already been introduced. Increasing access to ART plays 
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an important role in reducing co-morbidities and mortality. Nutritional interventions are 
paramount especially in HIV-infected children, where this should form an adjunct to ART. 
Mothers should be educated on the importance of proper nutrition in preventing infection.  
 
Although there was no specific identification of rotavirus infection in this analysis, 
rotavirus is likely to be the main cause of acute gastroenteritis in this cohort, based on 
results of previous studies as well as the seasonal distribution of the cases. The 
introduction of rotavirus vaccine into the EPI in South Africa is likely to decrease the 
burden of acute gastroenteritis in general, both in HIV-infected and HIV-uninfected 
children. With the high burden of disease in those under 6 months of age, early vaccination 
at 6 weeks and the booster dose at 14 weeks, should allow better protection against 
rotavirus at an early age.  
 
Further studies are needed to investigate the effect of the rotavirus vaccine once this is 
introduced at a population level. Although immunogenicity studies suggest that rotavirus 
vaccine is immunogenic in HIV-infected children, this needs to be confirmed in 
effectiveness trials. The vaccine needs to be assessed in different geographical locations as 
well as in situations with concomitant malnutrition and co-infection with other bacterial 
pathogens. Increasing ART usage in children is likely to impact the burden of acute 
gastroenteritis in a positive way and time series analyses will be useful in monitoring 
trends in acute gastroenteritis admissions at this and other hospitals in future. 
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APPENDICES 
Appendix A: Ethics clearance certificate for original study by Drs Klugman and Madhi 
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Appendix B: Case report form 
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Appendix C: Excerpt from International Disease Classification Code Book, Department of 
Paediatrics, Baragwanath Hospital. Based on ninth revision of WHO codes edition.  1990.  
        003.0 Salmonella gastroenteritis 
        003.1 Salmonella septicaemia 
          004 Shigella gastroenteritis 
        008.0 Enteropathic E coli gastroenteritis 
        008.5 Bacterial gastroenteritis 
        008.8 Viral gastroenteritis 
        009.3 Presumed infectious gastroenteritis 
        466.1 Bronchiolitis 
          480 Viral pneumonia 
          481 Lobar pneumonia 
          482 Bacterial pneumonia 
          485 Bronchopneumonia 
        485.0 Bronchopneumonia 
          260 Kwashiorkor 
          261 Marasmus 
          262 Marasmic Kwashiorkor 
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Appendix D – Denominator estimations for cumulative incidence calculations stratified by 
HIV status. 
 
HIV-Infected – assuming a prevalence of 6.47% at enrolment 
 
Age interval 
Total alive at 
beginning of age 
interval 
Number of 
deaths in age 
interval 
Total alive at 
end of the age 
interval 
Average 
number alive 
during age 
interval 
6 weeks- 5.9 
months 
2579 223 2356 2468 
6 - 11.9 months 2356 74 2282 2319 
12 - 23.9 months 2282 36 2246 2264 
24 – 59.9 months 2246 33 2213 2230 
Total 2579 366 2213 2396 
 
HIV-Uninfected 
 
Age interval 
Total alive at 
beginning of age 
interval 
Number of 
deaths in age 
interval 
Total alive at 
end of the age 
interval 
Average 
number alive 
during age 
interval 
6 weeks- 5.9 
months 
37300 43 37257 37279 
6 - 11.9 months 37257 20 37237 37247 
12 - 23.9 months 37237 17 37220 37229 
24 – 59.9 months 37220 12 37208 37214 
Total 37300 92 37208 37254 
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Appendix E: Ethics certificate for current secondary data analysis. 
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Purple bar – number of patients with non-rotavirus diarrhoea 
Blue bar – number of patients with rotavirus 
Line plot – percentage of patients that were rotavirus positive 
 
Data provided by Dr LM Seheri – MRC Diarrhoeal Pathogens Research Unit, University of Limpopo, Medunsa Campus, Department of 
Virology, South Africa. Presented at Vaccinology 2009, Hermanus, South Africa.
Appendix F: Seasonality of rotavirus diarrhoea at Dr George Mukhari Hospital 2005 - 2008 
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